You are here

Novartis

Good Phase III results for Novartis’ cancer drug (breast cancer)

GoinPharma

Sun, 08/26/18 - 12:05 pm

clinical trials

Novartis brings in new CEO to clean up scandal-hit Korean branch

Fierce Pharma

Fri, 08/24/18 - 11:06 am

Novartis’ PI3K drug hits goal in phase 3 breast cancer trial, laying groundwork for talks with regulators

Fierce Biotech

Thu, 08/23/18 - 10:19 am

clinical trials

Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals

Fierce Pharma

Wed, 08/22/18 - 11:44 am

Aimovig launch bolsters hopes for blockbuster sales

Biopharma Dive

Tue, 08/21/18 - 10:06 am

Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack

Endpoints

Fri, 08/17/18 - 09:28 am

wet age-related macular degeneration

CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess

Endpoints

Tue, 08/14/18 - 11:25 am

Vasant Narasimham

Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies

Fierce Pharma

Mon, 08/13/18 - 05:53 pm

Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line

Endpoints

Mon, 08/13/18 - 11:39 am

wet age-related macular degeneration

Why Novartis Stock Gained 11% in July

Motley Fool

Mon, 08/6/18 - 09:55 am

Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech

Fierce Biotech

Wed, 08/1/18 - 11:32 pm

pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in

RAPS.org

Thu, 07/26/18 - 07:28 pm

Gilead Sciences

drug-drug interactions

proton pump inhibitors

Omeros Prevails in Patent Dispute With Sandoz

CP Wire

Thu, 07/26/18 - 11:24 am

Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars

Endpoints

Wed, 07/25/18 - 10:24 am

Kymriah Manufacturing Issues Spell Trouble for Commercialization of Novartis CAR-T Therapy

Xtalks

Mon, 07/23/18 - 10:40 pm

drug manufacturing

Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices

Endpoints

Fri, 07/20/18 - 09:47 am

Trump thanks Novartis, Pfizer for not raising drug prices

Yahoo/Reuters

Thu, 07/19/18 - 10:00 am

Novartis to Pay as Much as $1 Billion for Rights to Skin Drug

Yahoo/Bloomberg

Thu, 07/19/18 - 09:53 am

atopic dermatitis

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Medical Marketing and Media

Wed, 07/18/18 - 10:49 pm

multiple sclerosis

FDA Approves First Cancer Drug Under New Real Time Review Program

CP Wire

Wed, 07/18/18 - 01:39 pm

Real Time Oncology Review

Pages